Clinical Trial Update: Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating conditioning with busulfan and cyclophosphamide followed by bone marrow transplantation in patients with acute myeloid leukemia or myel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• BUSULFAN (Busulfan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Northwestern University | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED